Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of SPARC0913. A multicenter,
open label, non-randomized, uncontrolled, single group assignment, safety study of subjects
with primary open angle glaucoma or ocular hypertension is planned. Subjects will receive
study medication for a period of 24-weeks.